Slovenian government accepted the “Plan for development of research infrastructure in 2010 – 2020” within ESFRI. According to this plan, project partners form Faculty of Medicine UL in 2011 became the Slovenian national ELIXIR node. D. Rozman was elected by the Government of the Republic Slovenia as the Slovenian representative in ELIXIR Interim Board (IB). The P.I. of this project B. Zupan was nominated as Scientific Board member which will be decided by IB in April 2012. The purpose of ELIXIR is to construct and operate a sustainable infrastructure for biological information in Europe to support life science research and its translation to medicine and the environment, the bio-industries and society. Due to new technologies such as next-generation DNA sequencing, data produced in biological experiments is doubling every few months, and this rate and new types of data are constantly increasing. There is an emerging need that data are integrated meaningfully. The collection, curation, storage, archiving, integration and deployment of biomolecular data is an immense challenge that cannot be handled by a single organisation or by one country alone, but requires international coordination. ELIXIR will operate through a core collection center, in addition to dispersed nodes. The key actors of the Slovenian node ELIXIR.si are partners of this project that will be in Slovenia responsible for (a) collection of post-genome data from different resources; (b) construction and integration of bio-computing centers; (c) construction and integration of infrastructure for integration of biological data, software, tools and services; (d) offering services to the research community, including training and standard development.
D.03 Membership in foreign/international boards/committees
- International Advisory Board on Cytochromes P450s - International Advisory Board of International Society for Studies of Xenobiotics (ISSX)- Award Committee - In 2010/2011 Expert of The Directorate for Health of the Research Directorate General EU, for "-omics" technologies in the development of personalised medicine and systems medicine. - Active member of the Advisory Board for Systems Biology at BMBF, the German Ministry of Science.
F.34 Consultancy
- Best business plan 2011 - Technology park Ljubljana - Best business plan 2011 - Start-up Slovenia - Best Start-up company 2011 - Start-up Slovenia - Runners up - Podjetna Primorska 2011 - Finalists of Deans award 2011 - Finalists UNICA Entrepreneurship competition 2011 - Participants of the 6th Slovenian forum of Innovations. The company has also repeatedly appeared in different forms of media (print, radio, Internet and television).
F.20 Company spin off